Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shohei Ueda

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Cancer Immunology, Immunotherapy : CII|August 11, 2021
Effect of HLA genotype on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancerMizuki Kobayashi, Nobuhiro Fujiyama, Tokiyoshi Tanegashima, et al.
Andrologia|November 8, 2021
Clinical impact of HSD3B1 polymorphism by metastatic volume and somatic HSD3B1 alterations in advanced prostate cancerMasaki Shiota, Naohiro Fujimoto, Yohei Sekino, et al.
Cancer Science|October 16, 2020
Gene amplification of YB-1 in castration-resistant prostate cancer in association with aberrant androgen receptor expressionMasaki Shiota, Yohei Sekino, Shigehiro Tsukahara, et al.
Oncoimmunology|April 11, 2018
Bladder cancer-associated cancer-testis antigen-derived long peptides encompassing both CTL and promiscuous HLA class II-restricted Th cell epitopes induced CD4<sup>+</sup> T cells expressing converged T-cell receptor genes <i>in vitro</i>Miki Tsuruta, Shohei Ueda, Poh Yin Yew, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Cancer Immunology, Immunotherapy : CII|August 11, 2021
Effect of HLA genotype on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancerMizuki Kobayashi, Nobuhiro Fujiyama, Tokiyoshi Tanegashima, et al.
Andrologia|November 8, 2021
Clinical impact of HSD3B1 polymorphism by metastatic volume and somatic HSD3B1 alterations in advanced prostate cancerMasaki Shiota, Naohiro Fujimoto, Yohei Sekino, et al.
Cancer Science|October 16, 2020
Gene amplification of YB-1 in castration-resistant prostate cancer in association with aberrant androgen receptor expressionMasaki Shiota, Yohei Sekino, Shigehiro Tsukahara, et al.
Oncoimmunology|April 11, 2018
Bladder cancer-associated cancer-testis antigen-derived long peptides encompassing both CTL and promiscuous HLA class II-restricted Th cell epitopes induced CD4<sup>+</sup> T cells expressing converged T-cell receptor genes <i>in vitro</i>Miki Tsuruta, Shohei Ueda, Poh Yin Yew, et al.
Pageof 3